Cancers arise as a result of genetic and epigenetic alterations. These accumulate in cells during the 15 processes of tissue development, homeostasis and repair. Many tumor types are hierarchically orga-16 nized and driven by a sub-population of cells often called cancer stem cells. Cancer stem cells are 17 uniquely capable of recapitulating the tumor and can be highly resistant to radio-and chemotherapy 18 treatment. We investigate tumor growth patterns from a theoretical standpoint and show how signif-19 icant changes in pre-and post-therapy tumor dynamics are tied to the dynamics of cancer stem cells. 20 We identify two characteristic growth regimes of a tumor population that can be leveraged to estimate 21 cancer stem cell fractions in vivo using simple linear regression. Our method is a mathematically exact 22 result, parameter free and does not require any microscopic knowledge of the tumor properties. A 23 more accurate quantification of the direct link between the sub-population driving tumor growth and 24 treatment response promises new ways to individualize treatment strategies. 25 Significance Statement 1 Under the cancer stem cell hypothesis a tumor population is driven by a fraction of self-renewing 2 cancer stem cells. Absolute and relative size of this population in human cancers at any stage of the 3 disease remains unknown. We formulate a mathematical model that describes the tumor cell 4 population's growth dynamics and response to therapy. This allows to estimate cancer stem cell 5 fraction from longitudinal measurements of tumor size (often available from imaging). Such estimates 6 are critical because treatment outcome and risk of relapse depend on the tumor's capacity to 7 self-renew. Ideally, by tailoring patient treatment strategies based on the relative abundance of cancer 8 stem cells could lead to radically different therapeutic regime and to the successful eradication of the 9 disease.
N 0 growth, as well as different treatment regimens. 1 The deterministic dynamics of a cell population that is organized in such a hierarchy can be described 2 by a set of coupled linear differential equations. The general analytical solution reduces to a set of 3 weighted exponential functions (see Methods for details). If there are a finite number of cell divisions, 4 the tumor growth curve decomposes into two regimes. The first regime is driven by cancer cells filling 5 up compartments of higher differentiation. The second phase is characterized by a dynamic 6 equilibrium, in which this drive from below is balanced by loss of cells due to senescence. In addition, 7 and more importantly, we can infer the impact of the fraction of cancer stem cells on possible 'phase 8 transitions' during tumor growth and response to treatment.
9
Tumor growth 10 We initiate tumor growth with a single (cancer stem) cell in compartment 0. This is in line with the 11 cancer stem cell hypothesis [43] and does not necessarily imply that the cell of origin was a stem cell.
12
Potentially stem like properties can be acquired at later stages of the hierarchy, as is common in for 13 example different acute leukemias [8, 28] . The proliferation parameters of cancer stem cells determine 14 the long term behavior of the tumor. A tumor grows continuously (and potentially becomes a 15 detectable cancer), if p > (1 + d)/2. The probability of stem cell self renewal p needs to be sufficiently 16 large to compensate loss of stem cells by random cell death d. In contrast, the tumor population 17 vanishes for insufficient cancer stem cell self renewal. In the following, we assume that p is 18 sufficiently large to allow for a growing tumor.
19
In this scenario, the population of cancer stem cells expands. In addition, cancer stem cells 20 differentiate into transient amplifying cells that comprise the bulk of the tumor. However, after The fraction of cancer stem cells r g at time t during tumor growth is given by where N 0 (t) corresponds to the number of stem cells, and is N (t) the sum of all tumor cells at time t. The value of the cancer stem cell fraction in dynamic equilibrium depends on the sign of the 8 differential flow between the stem and the non-stem compartments. This flow describes the difference 9 between the net expected growth of the cancer stem cell compartment and the net loss in any given 10 differentiated (non-stem) compartment due to cell differentiation or death.
11
If the differential flow is negative, more stem cells are lost by differentiation than gained by self 12 renewal. Then the stem cell fraction tends to zero. If the differential flow is exactly zero, cancer stem 13 cells furnish half of the tumor population. For positive values of the differential flow, we have a 14 surplus in the production of differentiated tumor cells as compared to their losses during further 15 differentiation. In this third case, one can show that the time dependent components converge to a 16 constant value N (t) /N 0 (t) ! const. and the fraction of cancer stem cells take a non trivial value 17 between 0 and 1, see Methods for details. Thus, the relative composition of the growing tumor 18 remains constant in the second phase of tumor growth and is given by Interestingly, one finds that the coefficient a coincides with the constant in the exact expression of r ⇤ g 10 and we can write r ⇤ g = 1/(1 + a). This observation allows us to estimate r ⇤ g from tumor growth curves.
Instead of calculating the parameter a analytically, one can fit an exponential function h g e a g t to a 
from an exponential fit h g e a g t to the tumor growth curve, see Fig. 2 for an illustrative example.
Estimating the cancer stem cell fraction under treatment 1 Our general approach allows us to implement treatment strategies by altering the death rates d (or of tumor shrinking, where the initial treatment effect starts to diminish.
12
The stem cell fraction that is active during treatment response can be estimated by an exponential fit 
.
(4) 20 This is an exact result of our model and its structure is very similar to the case of untreated tumor 21 growth, see Fig. 2 . However, we require additional information to estimate the fraction of cancer stem 22 cells under treatment, but this information can be gained from macroscopic observations with no 23 need for detailed knowledge about the microscopic tumor properties. The cancer stem cell hypothesis was formulated almost two decades ago and has attracted much 26 attention and research but also many critics and much skepticism ever since [45] . While the existence 27 of cancer stem cells in some tumors is well established, the situation in other cancers remains 28 somewhat unclear [9, 43] . However, its impact on the understanding and treatment of cancers is Further, differentiated cells can undergo a maximum of m cell doublings before they enter cell senescence. The system takes the form of a hierarchically coupled set of ordinary differential equations. The stem cell population obeys
and the first compartment follows
The function N 1 corresponds to the number of differentiated cells that have not undergone further proliferations and thus have m cell cycles left before they enter cell cycle arrest. For all higher compartments (2  i  m) we then have
where N m is the number of differentiated cells that only have a single cell cycle left after which they 3 enter cell cycle arrest and are removed.
4
The equations (5)-(7) can be solved recursively for general initial conditions. If we set N i (0) to be the initial number of cells at time t = 0 in compartment i, we find
for the time dependence of cancer stem cells and a = (1 + d 2p)c S is the net growth of cancer stem cells. The higher compartments (i > 0) evolve according to
The outflow of each differentiated compartment is b = (1 + d)c D and g = b a corresponds to the slower growth is determined by the signs of a and b. Both c D and d are strictly positive and 1 consequently all terms in (9) that contain exp ( bt) vanish in the long run. If we have p > (1 + d)/2, 2 a has a positive sign and determines tumor growth in the long run. Therefore, if we start from a 3 single cell, N 0 (0) = 1, and the initial conditions become negligible, the total number of differentiated 4 cells grows by
6 and follows a single exponential function a g e a g t , with an offset a g that involves all model parameters.
7
The fraction of cancer stem cells can be written generally as
and is given in the slower growth phase by
Similarly, during treatment, tumor growth in equilibrium can be written asN t = a t e a t t . However, in contrast to the tumor growth phase we get an additional term due to changed initial conditions.
Instead of a single seeding cancer stem cell, we have e a g T cancer stem cells at time of diagnosis T.
Consequently, the fraction of stem cells becomes r ⇤ t = 1 1 + a t e a g T .
By re-substituting the age of the tumor via 9 we find for the fraction of cancer stem cells under treatment
